Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00335) | |||||
---|---|---|---|---|---|
Name |
Isotretinoin
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
Isotretinoin; 13-cis-Retinoic acid; Accutane; 4759-48-2; Roaccutane; Neovitamin A acid; 13-cis-Vitamin A acid; 13-cis retinoic acid; Claravis; Amnesteem; Isotrex; Teriosal; Sotret; ISOTRETINON; isotretinoino; Isotretinoine; Isotretinoinum; Roaccutan; Absorica; Roacutan; Isotretinoine [INN-French]; Isotretinoinum [INN-Latin]; Isotretinoino [INN-Spanish]; CIP-Isotretinoin; Accutane (TN); Isotretinoin (USP); Ro-4-3780; UNII-EH28UP18IF; cis-RA; (7E,9E,11E,13Z)-retinoic acid; Ro 4-3780; (13cis)-retinoic acid; 13-cis RA; Ro-43780; CHEMBL547; EH28UP18IF; RETINOIC ACID, 13-cis-; CHEBI:6067; 13-cis-retinoic acid,Isotretinoin; Isotane; cis-Retinoic acid; Myorisan; Zenatane; Isosuprea Lidose; Sotret (TN); CCRIS 4286; HSDB 3929; 13 Cis-Retinoic Acid; SR-01000076103; EINECS 225-296-0; BRN 1885770; isotretinoina; cis-Retinoate; BML2-E07; Isotretinoin [USAN:BAN:INN]; MFCD00079542; cis retinoic acid; Trans-Retinoicacid; Absorica (TN); Prestwick_642; CAS-4759-48-2; Isotretinoin [USAN:USP:INN:BAN]; (13-cis)-Retinoate; CPD000471891; Prestwick2_000256; Prestwick3_000256; Spectrum5_001795; Spectrum5_001937; (13-cis)-Retinoic acid; DSSTox_CID_3177; R 3255; Retinoic acid 13-cis-form; Retinoic acid, (13cis)-; DSSTox_RID_76906; DSSTox_GSID_23177; Lopac0_001081; SCHEMBL38299; BSPBio_000072; BSPBio_001331; BSPBio_003345; 4-09-00-02388 (Beilstein Handbook Reference); MLS001074662; SPECTRUM1502013; BPBio1_000080; GTPL7600; DTXSID4023177; PAT-001; HMS1361C13; HMS1568D14; HMS1791C13; HMS1921D08; HMS1989C13; HMS2092N07; HMS2095D14; HMS2233A07; HMS3259J09; HMS3263I04; HMS3402C13; HMS3712D14; HMS3884A13; Pharmakon1600-01502013; BCP18950; ZINC3792789; Tox21_200093; Tox21_501081; BDBM50031459; LMPR01090021; NSC758156; AKOS015841158; CCG-205158; CS-1864; DB00982; DS-3367; LP01081; NC00635; NSC-758156; SDCCGSBI-0051051.P004; IDI1_033801; NCGC00094358-01; NCGC00094358-02; NCGC00094358-03; NCGC00094358-04; NCGC00094358-05; NCGC00094358-06; NCGC00094358-07; NCGC00094358-08; NCGC00094358-09; NCGC00094358-10; NCGC00094358-11; NCGC00094358-12; NCGC00094358-13; NCGC00094358-14; NCGC00094358-15; NCGC00094358-26; NCGC00257647-01; NCGC00261766-01; HY-15127; SMR000471891; 13-cis-Retinoic acid, >=98% (HPLC); 13-cis-Retinoic acid; Retinoid analogues; SBI-0051051.P003; EU-0101081; 5952-EP0930075A1; 5952-EP2295426A1; 5952-EP2311840A1; 59I482; C07058; D00348; 24210-EP2311808A1; 24210-EP2311829A1; 24210-EP2314590A1; Q287029; SR-01000076103-2; SR-01000076103-5; SR-01000076103-6; SR-01000076103-9; BRD-K76723084-001-05-9; SR-01000076103-10; Isotretinoin, European Pharmacopoeia (EP) Reference Standard; Isotretinoin, United States Pharmacopeia (USP) Reference Standard; Isotretinoin, Pharmaceutical Secondary Standard; Certified Reference Material
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Acne vulgaris | ICD-11: ED80 | [1] | ||
PubChem CID | |||||
Formula |
C20H28O2
|
||||
Canonical SMILES |
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C
|
||||
InChI |
1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-
|
||||
InChIKey |
SHGAZHPCJJPHSC-XFYACQKRSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5282379"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 300.4 | Topological Polar Surface Area | 37.3 | |
XlogP | 6.3 | Complexity | 567 | ||
Heavy Atom Count | 22 | Rotatable Bond Count | 5 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Isotretinoin 30 mg capsule | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Alpha.-tocopherol; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Butylated hydroxyanisole; Edetate disodium; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Polysorbate 80; Gelatin; Hydrogenated soybean oil; Shellac; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [3] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [4] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Alpha.-tocopherol; Fd&c blue no. 1; Fd&c blue no. 2; Butylated hydroxyanisole; Edetate disodium; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Polysorbate 80; Aluminum oxide; Cottonseed oil; Gelatin; Shellac; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [3] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [4] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Butyl alcohol; Fd&c blue no. 2; Propylparaben; Butylated hydroxyanisole; Edetate disodium; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Medium-chain triglycerides; Gelatin; Hydrogenated soybean oil; Shellac; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Dr Reddy's Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [6] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Medium-chain triglyceride | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 36 %) | [7] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol, dl-; Butyl alcohol; Isopropyl alcohol; Sorbitol; Ammonia; Butylated hydroxyanisole; Edetate disodium; Ferric oxide red; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Alcohol; Gelatin; Hydrogenated soybean oil; Shellac; Soybean oil; Yellow wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | VersaPharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
DL-alpha-tocopherol | DIG Info | Presenilin 1 (EC50 > 100000 nM) | [10] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [11] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sodium hydroxide; Titanium dioxide; Gelatin; Peg-32 hydrogenated palm glycerides; Povidones; Shellac; Soybean oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Ranbaxy Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sodium hydroxide; Titanium dioxide; Gelatin, unspecified; Peg-32 hydrogenated palm glycerides; Shellac; Soybean oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c yellow no. 6; Butylated hydroxyanisole; Edetate disodium; Glycerin; Titanium dioxide; Gelatin; Hydrogenated soybean oil; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Amneal Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Isotretinoin 10 mg capsule | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; D&c yellow no. 10; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Propylparaben; Butylated hydroxyanisole; Edetate disodium; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Medium-chain triglycerides; Gelatin; Hydrogenated soybean oil; Shellac; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Dr Reddy's Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [4] | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [6] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Medium-chain triglyceride | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 36 %) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; D&c red no. 7; Fd&c yellow no. 6; Butylated hydroxyanisole; Edetate disodium; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Polysorbate 80; Gelatin; Hydrogenated soybean oil; Shellac; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol, dl-; Butyl alcohol; Isopropyl alcohol; Sorbitol; Ammonia; Butylated hydroxyanisole; Edetate disodium; Ferric oxide yellow; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Alcohol; Gelatin; Hydrogenated soybean oil; Shellac; Soybean oil; Yellow wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | VersaPharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
DL-alpha-tocopherol | DIG Info | Presenilin 1 (EC50 > 100000 nM) | [10] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [11] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Propyl gallate; Ferric oxide yellow; Potassium hydroxide; Propylene glycol; Titanium dioxide; Gelatin; Peg-32 hydrogenated palm glycerides; Shellac; Soybean oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Ranbaxy Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Propyl gallate; Ferric oxide yellow; Potassium hydroxide; Propylene glycol; Titanium dioxide; Gelatin, unspecified; Peg-32 hydrogenated palm glycerides; Shellac; Soybean oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxyanisole; Edetate disodium; Ferric oxide yellow; Ferrosoferric oxide; Glycerin; Titanium dioxide; Gelatin; Hydrogenated soybean oil; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Amneal Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxyanisole; Edetate disodium; Ferric oxide red; Glycerin; Soybean oil; Yellow wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Mylan Pharamceuticals; Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Isotretinoin 20 mg capsule | Click to Show/Hide the Full List of Formulation(s): 9 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; D&c red no. 30; Butyl alcohol; D&c red no. 27; Fd&c blue no. 2; Propylparaben; Butylated hydroxyanisole; Edetate disodium; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Medium-chain triglycerides; Gelatin; Hydrogenated soybean oil; Shellac; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Dr Reddy's Laboratories; Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [6] | |||
D&C red no. 27 | DIG Info | Solute carrier SLCO2B1 (Ki = 1 uM) | [4] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [8] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Medium-chain triglyceride | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 36 %) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol, dl-; Butyl alcohol; Isopropyl alcohol; Sorbitol; Ammonia; Butylated hydroxyanisole; Edetate disodium; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Alcohol; Gelatin; Hydrogenated soybean oil; Shellac; Soybean oil; Yellow wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | VersaPharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
DL-alpha-tocopherol | DIG Info | Presenilin 1 (EC50 > 100000 nM) | [10] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [11] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Butyl alcohol; Isopropyl alcohol; Sorbitol; Ammonia; Butylated hydroxyanisole; Edetate disodium; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Alcohol; Gelatin; Shellac; Soybean oil; Yellow wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [3] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [11] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Ammonia; Butylated hydroxyanisole; Edetate disodium; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Polysorbate 80; Cottonseed oil; Dimethicone; Gelatin; Shellac; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Ammonia; Butylated hydroxyanisole; Edetate disodium; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Polysorbate 80; Dimethicone 350; Gelatin; Hydrogenated soybean oil; Shellac; Silica, trimethylsilyl capped; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Propyl gallate; Ferric oxide red; Potassium hydroxide; Propylene glycol; Titanium dioxide; Gelatin; Peg-32 hydrogenated palm glycerides; Shellac; Soybean oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Ranbaxy Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Propyl gallate; Ferric oxide red; Potassium hydroxide; Propylene glycol; Titanium dioxide; Gelatin, unspecified; Peg-32 hydrogenated palm glycerides; Shellac; Soybean oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxyanisole; Edetate disodium; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Glycerin; Titanium dioxide; Gelatin; Hydrogenated soybean oil; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Amneal Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxyanisole; Edetate disodium; Ferric oxide red; Ferric oxide yellow; Glycerin; Titanium dioxide; Soybean oil; Yellow wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Mylan Pharamceuticals; Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Isotretinoin 40 mg capsule | Click to Show/Hide the Full List of Formulation(s): 9 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; D&c yellow no. 10; Butyl alcohol; Fd&c blue no. 1; Fd&c blue no. 2; Propylparaben; Butylated hydroxyanisole; Edetate disodium; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Medium-chain triglycerides; Gelatin; Hydrogenated soybean oil; Shellac; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Dr Reddy's Laboratories; Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [4] | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [6] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Medium-chain triglyceride | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 36 %) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Alpha.-tocopherol; Fd&c blue no. 2; Fd&c yellow no. 6; Ammonia; Butylated hydroxyanisole; Edetate disodium; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Polysorbate 80; Silicon dioxide; Aluminum oxide; Cottonseed oil; Gelatin; Shellac; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [4] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [4] | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [9] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol, dl-; Butyl alcohol; Fd&c yellow no. 6; Isopropyl alcohol; Sorbitol; Ammonia; Butylated hydroxyanisole; Edetate disodium; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Alcohol; Gelatin; Hydrogenated soybean oil; Shellac; Soybean oil; Yellow wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | VersaPharm | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [4] | |||
DL-alpha-tocopherol | DIG Info | Presenilin 1 (EC50 > 100000 nM) | [10] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [11] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Butyl alcohol; Fd&c yellow no. 6; Isopropyl alcohol; Sorbitol; Ammonia; Butylated hydroxyanisole; Edetate disodium; Ferrosoferric oxide; Glycerin; Propylene glycol; Titanium dioxide; Alcohol; Gelatin; Shellac; Soybean oil; Yellow wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [4] | |||
Isopropyl alcohol | DIG Info | Lymphoma P388/ADR cells (IC50 = 0.22 uM) | [11] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Alpha.-tocopherol; Fd&c yellow no. 6; Ammonia; Butylated hydroxyanisole; Edetate disodium; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Polysorbate 80; Gelatin; Hydrogenated soybean oil; Shellac; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Alpha-tocopherol | DIG Info | Glutathione S-transferase P (IC50 = 500 nM) | [3] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [4] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [2] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sodium hydroxide; Titanium dioxide; Gelatin; Peg-32 hydrogenated palm glycerides; Povidones; Shellac; Soybean oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Ranbaxy Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Sodium hydroxide; Titanium dioxide; Gelatin, unspecified; Peg-32 hydrogenated palm glycerides; Shellac; Soybean oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c yellow no. 6; Butylated hydroxyanisole; Edetate disodium; Glycerin; Titanium dioxide; Gelatin; Hydrogenated soybean oil; Soybean oil; White wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Amneal Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [4] | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Butylated hydroxyanisole; Edetate disodium; Ferric oxide red; Ferric oxide yellow; Glycerin; Titanium dioxide; Soybean oil; Yellow wax
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Mylan Pharamceuticals; Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Butylhydroxyanisole | DIG Info | Prostaglandin G/H synthase 2 (IC50 = 2.6 uM) | [2] | |||
Isotretinoin 25 mg capsule | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Fd&c blue no. 1; Fd&c yellow no. 5; Fd&c yellow no. 6; Propyl gallate; Propylene glycol; Sodium hydroxide; Titanium dioxide; Gelatin, unspecified; Peg-32 hydrogenated palm glycerides; Shellac; Soybean oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [4] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [4] | |||
Hydrazine yellow | DIG Info | GABA(A) receptor alpha-1 (IC50 = 13 uM) | [2] | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Fd&c blue no. 1; Fd&c yellow no. 5; Fd&c yellow no. 6; Propyl gallate; Propylene glycol; Sodium hydroxide; Titanium dioxide; Gelatin; Peg-32 hydrogenated palm glycerides; Povidones; Shellac; Soybean oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Ranbaxy Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [4] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [4] | |||
Hydrazine yellow | DIG Info | GABA(A) receptor alpha-1 (IC50 = 13 uM) | [2] | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Isotretinoin 35 mg capsule | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Fd&c blue no. 2; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Sodium hydroxide; Titanium dioxide; Gelatin, unspecified; Peg-32 hydrogenated palm glycerides; Shellac; Soybean oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Sun Pharmaceutical Industries | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Fd&c blue no. 2; Propyl gallate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Sodium hydroxide; Titanium dioxide; Gelatin; Peg-32 hydrogenated palm glycerides; Povidones; Shellac; Soybean oil
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Ranbaxy Laboratories | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
Propyl gallate | DIG Info | Arachidonate 5-lipoxygenase (Ki = 0.43 uM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.